2rf9
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{Seed}} | ||
[[Image:2rf9.png|left|200px]] | [[Image:2rf9.png|left|200px]] | ||
Line 12: | Line 11: | ||
===Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide=== | ===Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide=== | ||
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_18046415}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 18046415 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_18046415}} | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[2rf9]] is a 4 chain structure of [[Epidermal Growth Factor Receptor]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RF9 OCA]. | |
+ | |||
+ | ==See Also== | ||
+ | *[[Epidermal Growth Factor Receptor]] | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:18046415</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
Line 44: | Line 55: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
[[Category: Ubl conjugation]] | [[Category: Ubl conjugation]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 10:57:57 2009'' |
Revision as of 09:31, 26 December 2010
Contents |
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide
Template:ABSTRACT PUBMED 18046415
About this Structure
2rf9 is a 4 chain structure of Epidermal Growth Factor Receptor with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature. 2007 Nov 29;450(7170):741-4. PMID:18046415 doi:nature05998
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Bose, R. | Cole, P A. | Jura, N. | Kuriyan, J. | Pickin, K A. | Zhang, X. | Alternative splicing | Anti-oncogene | Atp-binding | Cell cycle | Cytoplasm | Dimer | Disease mutation | Glycoprotein | Inhibition | Kinase domain | Membrane | Nucleotide-binding | Peptide | Phosphorylation | Polymorphism | Receptor | Secreted | Transferase | Transmembrane | Tyrosine-protein kinase | Ubl conjugation